[HTML] thelancet.comFull View

[HTML][HTML] Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - …, 2022 - thelancet.com
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …
被引用次数：23 相关文章

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: a systematic review and meta-analysis.

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - 2022 - cabidigitallibrary.org
Background: Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …
[HTML] sciencedirect.com

[HTML][HTML] Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - eClinicalMedicine, 2022 - Elsevier
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …
[PDF] researchgate.net

[PDF][PDF] Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Ronn, N Soni, ME Bellerose… - 2022 - researchgate.net
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …
[HTML] nih.gov

[HTML][HTML] Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - …, 2022 - ncbi.nlm.nih.gov
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis.

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - …, 2022 - europepmc.org
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni… - …, 2022 - researchonline.lshtm.ac.uk
BACKGROUND: Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …
[PDF] usp.br

[PDF][PDF] Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Ronn, N Soni, ME Bellerose… - 2022 - edisciplinas.usp.br
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis

L Staadegaard, MM Rönn, N Soni… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …

Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis.

L Staadegaard, MM Rönn, N Soni, ME Bellerose… - …, 2022 - europepmc.org
Background Vaccines have been demonstrated to protect against high-risk human
papillomavirus infection (HPV), including HPV-16/18, and cervical lesions among HIV …